Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-2-26
|
pubmed:abstractText |
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor that stimulates myeloid cell proliferation and maturation and enhances the function of terminally differentiated effector cells. Phase I and II clinical trials have demonstrated mild to moderate toxicities at doses of less than 30 micrograms/kg/day. These studies suggest a potential role for this growth factor to stimulate myelopoiesis in patients with aplastic anemia, myelodysplastic syndromes, AIDS, chemotherapy-induced myelosuppression, chronic neutropenia, and following bone marrow transplantation. The potential clinical uses of GM-CSF will depend on results of studies designed to optimize its therapeutic efficacy.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0737-1454
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
531-41
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1770227-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:1770227-Anemia, Aplastic,
pubmed-meshheading:1770227-Blood Cell Count,
pubmed-meshheading:1770227-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:1770227-Hematopoietic Stem Cells,
pubmed-meshheading:1770227-Humans,
pubmed-meshheading:1770227-Myelodysplastic Syndromes,
pubmed-meshheading:1770227-Neutropenia
|
pubmed:year |
1991
|
pubmed:articleTitle |
Clinical applications of human granulocyte-macrophage colony-stimulating factor.
|
pubmed:affiliation |
Department of Pediatrics, UCLA School of Medicine 90024-1752.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review,
Research Support, Non-U.S. Gov't
|